학술논문
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)
Document Type
Article
Author
Cafaro, A.; Masini, C.; Foca, F.; Nanni, O.; Chiumente, M.; Coppola, M.; Baldo, P.; Orzetti, S.; Enrico, F.; Ladisa, V.; Lerose, R.; Nardulli, P.; Maiolino, P.; Gradellini, F.; Gasbarro, A.R.; Carrucciu, G.; Provasi, R.; Cappelletto, P.C.; Pasqualini, A.; Vecchia, S.; Veraldi, M.; De Francesco, A.E.; Crinò, L.; Delmonte, A.
Source
In: Frontiers in Oncology . (Frontiers in Oncology, 2024, 14)
Subject
Language
English
ISSN
2234943X